Goldman Sachs Group Inc Lyra Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 555,508 shares of LYRA stock, worth $111,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
555,508
Previous 547,339
1.49%
Holding current value
$111,101
Previous $142,000
18.31%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LYRA
# of Institutions
54Shares Held
26.2MCall Options Held
21KPut Options Held
0-
Perceptive Advisors LLC New York, NY12.8MShares$2.55 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$565,9950.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.97MShares$393,1370.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$357,4840.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$211,6290.04% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $6.37M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...